{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:50:52Z","timestamp":1779889852853,"version":"3.53.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00927","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T16:39:38Z","timestamp":1593189578000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach"],"prefix":"10.3389","volume":"11","author":[{"given":"Liyuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Delavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Mikailov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","article-title":"An automated method for finding molecular complexes in large protein interaction networks","volume":"4","author":"Bader","year":"2003","journal-title":"BMC Bioinf."},{"key":"B2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10545-017-0055-1","article-title":"High-content drug screening for rare diseases","volume":"40","author":"Bellomo","year":"2017","journal-title":"J. Inherited Metab. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1161\/CIRCRESAHA.109.209338","article-title":"Protein Acetylation in the Cardiorenal Axis","volume":"106","author":"Bush Erik","year":"2010","journal-title":"Circ. Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/bib\/bbv020","article-title":"A survey of current trends in computational drug repositioning","volume":"17","author":"Butte","year":"2015","journal-title":"Briefings Bioinf."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.4155\/fmc.14.88","article-title":"Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention","volume":"6","author":"Butterworth","year":"2014","journal-title":"Future Med. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/nature09005","article-title":"Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome","volume":"465","author":"Carvajal-Vergara","year":"2010","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13023-017-0614-4","article-title":"Opportunities for developing therapies for rare genetic diseases: focus on gain-of-function and allostery","volume":"12","author":"Chen","year":"2017","journal-title":"Orphanet J. rare Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.drudis.2017.10.009","article-title":"Computational drug repositioning for rare diseases in the era of precision medicine","volume":"23","author":"Delavan","year":"2018","journal-title":"Drug Discovery Today"},{"key":"B9","doi-asserted-by":"publisher","first-page":"96ra76","DOI":"10.1126\/scitranslmed.3002648","article-title":"Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease","volume":"3","author":"Dudley","year":"2011","journal-title":"Sci. Trans. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","article-title":"miRWalk \u2013 Database: Prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes","volume":"44","author":"Dweep","year":"2011","journal-title":"J. Biomed. Inf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","article-title":"In silico repositioning of approved drugs for rare and neglected diseases","volume":"16","author":"Ekins","year":"2011","journal-title":"Drug Discovery Today"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9806","DOI":"10.1073\/pnas.1301509110","article-title":"Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy","volume":"110","author":"Ferguson","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1021\/acs.jmedchem.6b00680","article-title":"Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor","volume":"59","author":"Garcia Fortanet","year":"2016","journal-title":"J. Med. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41540-018-0050-7","article-title":"Large-scale computational drug repositioning to find treatments for rare diseases","volume":"4","author":"Govindaraj","year":"2018","journal-title":"NPJ Syst. Biol. Appl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New Method for Fast and Accurate Binding-site Identification and Analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2008","journal-title":"Nat. Protoc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14621","DOI":"10.1073\/pnas.1000138107","article-title":"Discovery of drug mode of action and drug repositioning from transcriptional responses","volume":"107","author":"Iorio","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","article-title":"Transcriptional data: a new gateway to drug repositioning","volume":"18","author":"Iorio","year":"2013","journal-title":"Drug Discovery Today"},{"key":"B19","doi-asserted-by":"publisher","first-page":"D937","DOI":"10.1093\/nar\/gkx1062","article-title":"eRAM: encyclopedia of rare disease annotations for precision medicine","volume":"46","author":"Jia","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/msb.20145092","article-title":"Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations","volume":"10","author":"Kiel","year":"2014","journal-title":"Mol. Syst. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/gim.2016.32","article-title":"Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation","volume":"18","author":"Kouz","year":"2016","journal-title":"Genet.  Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood-2005-02-0531","article-title":"The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease","volume":"106","author":"Kratz","year":"2005","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/s0008-6363(01)00354-6","article-title":"Heat shock proteins and cardiac protection","volume":"51","author":"Latchman","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13073-014-0094-2","article-title":"Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis","volume":"6","author":"Liu","year":"2014","journal-title":"Genome Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.tips.2016.06.010","article-title":"Potential Reuse of Oncology Drugs in the Treatment of Rare Diseases","volume":"37","author":"Liu","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tips.2018.12.001","article-title":"Toxicogenomics: A 2020 Vision","volume":"40","author":"Liu","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.celrep.2015.09.019","article-title":"Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia","volume":"13","author":"Mulero-Navarro","year":"2015","journal-title":"Cell Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-3-13","article-title":"Leopard syndrome","volume":"3","author":"Sarkozy","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"B33","first-page":"597","article-title":"New Effect Size Rules of Thumb","volume-title":"J. Mod. Appl. Stat. Methods","author":"Sawilowsky","year":"2009"},{"key":"B34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng1748","article-title":"Germline KRAS mutations cause Noonan syndrome","volume":"38","author":"Schubbert","year":"2006","journal-title":"Nat. Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","article-title":"Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data","volume":"3","author":"Sirota","year":"2011","journal-title":"Sci. Trans. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.genom.6.080604.162305","article-title":"Noonan Syndrome and Related Disorders: Genetics and Pathogenesis","volume":"6","author":"Tartaglia","year":"2005","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000276766","article-title":"Noonan syndrome: clinical aspects and molecular pathogenesis","volume":"1","author":"Tartaglia","year":"2010","journal-title":"Mol. Syndromol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat Shock Proteins and Cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"D464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy","volume":"47","author":"Yang","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e90220","DOI":"10.1172\/jci.insight.90220","article-title":"Low-dose dasatinib rescues cardiac function in Noonan syndrome","volume":"1","author":"Yi","year":"2016","journal-title":"JCI Insight"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1021\/acs.chemrev.7b00105","article-title":"Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases","volume":"118","author":"Yu","year":"2018","journal-title":"Chem. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T16:39:46Z","timestamp":1593189586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":43,"alternative-id":["10.3389\/fphar.2020.00927"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00927","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"article-number":"927"}}